Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmi⦠read more
Healthcare
Drug ManufacturersāSpecialty & Generic
6 years
USD
Exclusive to Premium users
$9.45
Price+0.64%
$0.06
$2.968b
Mid
945x
Premium
Premium
-1.6%
EBITDA Margin-13.9%
Net Profit Margin-3.7%
Free Cash Flow Margin$2.853b
+4.3%
1y CAGR+6.0%
3y CAGR+5.8%
5y CAGR$3.375m
-100.8%
1y CAGR-465.7%
3y CAGR-366.9%
5y CAGR$0.01
-16.7%
1y CAGR-448.4%
3y CAGR-354.2%
5y CAGR-$46.731m
$3.423b
Assets$3.470b
Liabilities$2.582b
Debt75.4%
8.9x
Debt to EBITDA$262.479m
-55.0%
1y CAGR+338.5%
3y CAGR+244.0%
5y CAGR